Zug, Switzerland and Vienna, Austria – April 5, 2019: The highly successful thirteenth annual BIO-Europe Spring® international partnering conference wrapped up in Vienna, Austria, last week with a record 2,570 biotech, pharma and investment attendees who engaged in 15,428 one-to-one partnering meetings vying for over 3,600 licensing opportunities on offer. The event welcomed 1,465 companies overall.
BIO-Europe Spring was produced by EBD Group and hosted by LISAvienna, a joint life science platform operated by the Vienna Business Agency and Austria Wirtschaftsservice on behalf of the Austrian Federal Ministry for Digital and Economic Affairs and the City of Vienna.
“We are very pleased that our delegates had such positive meetings at BIO-Europe Spring in Vienna toward facilitating valuable deals for the development of therapies and cures,” said Anna Chrisman, Managing Director of EBD Group and KNect365 Life Sciences. “We look forward to returning to Paris in 2020 for another great event.”
“It was a great honor for LISAvienna to host BIO-Europe Spring 2019 in Vienna,” said Johannes Sarx, Managing Director of LISAvienna. “The conference was a wonderful opportunity to present Austria`s capital city as Central Europe`s life sciences hub. With the highest numbers of participants, companies and partnering meetings ever, BIO-Europe Spring Vienna achieved record results. The rapid transformation of the industry was demonstrated by the lively discussions on current trends like digital health and the application of artificial intelligence in drug discovery. LISAvienna and EBD Group also provided valuable networking opportunities for all attendees at the historic venues of the imperial Hofburg and the glamorous Vienna City Hall.”
BIO-Europe Spring 2020 will be held for the second time in Paris, France, March 23–25, 2020, and is hosted by Medicen Paris Region.
“We are very excited to be working with EBD Group to make their springtime flagship event a big success in Paris,” said Stephane Roques, CEO of Medicen Paris Region, the world-class life sciences cluster for the Paris region. “The health-tech ecosystem of the Paris Region is so rich and innovative that it is a great place to find the best experts—clinicians, scientists, startups—to design and build a strong collaborative project and, in the end, a high-level therapeutic solution brought to the market.”
Roques said, “France has strong assets to develop combined health solutions for the medicine of the future due to the cross-fertilization between IT, engineers and AI schools and key opinion leaders from academic and clinical research. We are particularly strong in digital health, innovative biotherapies, biological diagnostic and medical imaging, applied to all therapeutic areas (oncology, neurosciences, immunology, infectiology…).”
The event program in Vienna highlighted underserved therapeutic areas, Asia-Pacific trends, investing, digital medicine NASH, cell and gene therapies, oncology partnering, the microbiome, a Startup Spotlight featuring innovative biotech companies and a Labiotech Refresh event addressing the outlook for European biotech.
BIO-Europe Spring is the most significant industry event of the year so far where top life science executives come together to access hundreds of potential partners to make their companies’ collaborative goals a reality.
For continuing news coverage about BIO-Europe Spring, including video interviews and articles on life science dealmaking, go to Partnering Insight or follow the conference hashtag #BIOEuropeSpring on Twitter.
# # #
Additional links and information:
About EBD Group
EBD Group’s overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.
Today our events (BIO-Europe®, BIO-Europe Spring®, BioPharm America™, Biotech Showcase™, China Showcase, Digital Medicine & Medtech Showcase, ChinaBio® Partnering Forum, Rare Disease Innovation and Partnering Summit, Cell & Gene Meeting on the Med, and BioEquity Europe) annually attract more than 15,000 senior life science executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.
Tune into EBD Group’s Partnering Insight for timely coverage of news that influences the business strategies of the life science industry. EBD Group is an Informa company. For more information please visit www.ebdgroup.com.
Raimund Gabriel, MC Services AG, +49 89 2102280, email@example.com
Kari Bennett, EBD Group, +1 (760) 930-0500, firstname.lastname@example.org